Structure Therapeutics (GPCR) Equity Ratio (2022 - 2026)

Structure Therapeutics' Equity Ratio history runs 5 years deep, the most recent figure standing at 0.96 for Q1 2026.

• In Q1 2026, Equity Ratio rose 0.83% year-over-year to 0.96; the TTM figure through Mar 2026 stood at 0.96 (up 0.83% YoY), while the FY2025 annual figure was 0.96, changed 0.0% from the prior year.
• Equity Ratio was 0.96 for Q1 2026 at Structure Therapeutics, roughly flat from 0.96 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.97 in Q2 2024 to a low of 1.18 in Q4 2022.
• Historically, Equity Ratio has averaged 0.79 across 5 years, with a median of 0.95 in 2025.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio soared 179.86% in 2023, then slipped 3.71% in 2025.
• A 5-year view of Equity Ratio shows it stood at 1.18 in 2022, then jumped by 179.86% to 0.94 in 2023, then rose by 1.88% to 0.96 in 2024, then slipped by 0.0% to 0.96 in 2025, then increased by 0.23% to 0.96 in 2026.
• The last three Equity Ratio figures came in at 0.96 (Q1 2026), 0.96 (Q4 2025), and 0.93 (Q3 2025), per Business Quant data.